<span item_type="fundamental" item_id="0b0a549ca38c44ae7c856f541d9bbd6d" counter_id="ST/US/BLDEW" env="prod"></span><span item_type="announcement" item_id="546043877938561665" env="prod"></span><p>Revenue: As of FY2025 Q2, the actual value is USD 70.8 M.</p><p>EPS: As of FY2025 Q2, the actual value is USD -0.05.</p><p></p><h3>Segment Revenue</h3><ul><li><strong>Medical Revenue</strong>: Increased 17.6% year-over-year to $45.1 million in Q2 2025, driven by new customers and increased revenue per block hour, despite a moderation in block hours per air trip.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1779128/000177912825000058/blde-earningreleasexq22025.htm"></span></li><li><strong>Passenger Revenue</strong>: Decreased 13.2% to $25.7 million in Q2 2025, with Short Distance revenue down 17.8% to $17.2 million and Jet and Other revenue down 2.3% to $8.5 million.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1779128/000177912825000058/blde-earningreleasexq22025.htm"></span></li></ul><h3>Operational Metrics</h3><ul><li><strong>Net Loss</strong>: Improved by $7.6 million to - $3.7 million in Q2 2025, primarily due to a $7.2 million improvement in loss from operations and higher non-operating income.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1779128/000177912825000058/blde-earningreleasexq22025.htm"></span></li><li><strong>Gross Profit</strong>: Increased 13.7% to $12.9 million, with a gross margin of 18.2% in Q2 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1779128/000177912825000058/blde-earningreleasexq22025.htm"></span></li><li><strong>Adjusted EBITDA</strong>: Increased by $2.2 million to $3.2 million in Q2 2025, driven by improvements in both Passenger and Medical segments.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1779128/000177912825000058/blde-earningreleasexq22025.htm"></span></li></ul><h3>Cash Flow</h3><ul><li><strong>Operating Cash Flow</strong>: Was - $3.1 million in Q2 2025, primarily due to an increase in working capital as revenue grew 30.4% compared to Q1 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1779128/000177912825000058/blde-earningreleasexq22025.htm"></span></li><li><strong>Free Cash Flow, Before Aircraft Acquisitions</strong>: Was - $5.7 million in Q2 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1779128/000177912825000058/blde-earningreleasexq22025.htm"></span></li></ul><h3>Unique Metrics</h3><ul><li><strong>Flight Profit</strong>: Increased 8.5% to $17.7 million in Q2 2025, with a Flight Margin of 25.1%.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1779128/000177912825000058/blde-earningreleasexq22025.htm"></span></li></ul><h3>Outlook / Guidance</h3><ul><li>The divestiture of Blade’s Passenger division is expected to be neutral to Adjusted EBITDA and Free Cash Flow on a go-forward annualized basis. The company reaffirms its 2025 revenue and Adjusted EBITDA guidance on a full-company basis, excluding the impact of the divestiture, with expected revenue of $245-265 million and double-digit Adjusted EBITDA.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1779128/000177912825000058/blde-earningreleasexq22025.htm"></span></li></ul>

BLDEW

BLADE AIR MOBILITY INC C/WTS 07/05/2026 (TO PUR COM) | 8-K: FY2025 Q2 Revenue: USD 70.8 M